HORSHAM: NMS Labs, a forensic science and bioanalytical toxicology laboratories, announced today that Dan T. Monahan is the now President and Chief Executive Officer of the Company.

Mr. Monahan will build upon NMS Labs’ success and provide leadership in advancing the organization’s strategic growth and expansion initiatives.

“It is a great honor and incredibly humbling to have the opportunity to lead a successful, purpose-driven organization,” said Mr. Monahan. “NMS Labs has tremendous expertise and is poised for growth in the industries we serve. When you couple that with our accomplished colleagues who have a passion for the work they perform, we will achieve true success together.”

“It is with great pleasure that we announce Daniel Monahan as President and CEO of NMS Labs. He has a strong analytical mindset and compelling vision for the future of our company. We are confident in his ability to build upon the many successes NMS Labs has already achieved and look forward to his leadership in advancing our strategic growth initiatives,” stated company owners Michael F. Rieders and Eric F. Rieders.

“With the commitment to the values and mission of our 50-year-old business and infusion of new leadership, we look forward to an ever-brighter future.”

NMS Labs is a leading bioanalytical toxicology and forensic sciences laboratory providing esoteric clinical and forensic services to physicians, attorneys, the criminal justice system, clinical reference labs, pharmaceutical companies, and consumer products manufacturers.

As part of our services, NMS Labs’ professionals interpret our laboratory testing results to resolve client-specific issues and provide expert witness testimony and consulting support for both civil and criminal judicial proceedings.